2011

A conversation with Preeti Pinto, Principal at Preeti Pinto Consulting, LLC and former Executive Director & Head of Promotional Regulatory Affairs at AstraZeneca US, about the use of comparative effectiveness and health outcomes data in the support of drug promotion to physicians, payers, and consumers.

David Epstein, head of Novartis Pharmaceuticals, said eighty percent of his company's sales reps will give up their PCs for iPads in 2012. Will they do it?

Welcome to Volume 10, Issue #14 (22 SEPTEMBER 2011) of Pharma Marketing News.

Public health officials cannot depend upon their noses to make important decisions. They need actionable real time data. How do they get it?

A conversation with Casey Quinlan, 'Mighty Mouth' at Mighty Casey Media LLC, Zoe Dunn, Principal, Hale Advisors, Richard Meyer, Principal Consultant, Online Strategic Solutions, Jerry Hall, Digital Media Executive, Advisor to Pearescope, about engaging and marketing to women online, especially via social media, which some new media marketers claim is 'all about women.'

Are we witnessing an exodus of social media

A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.

Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.

A Search Ad Format That Has All FDA Could Want... But Pharma Can't Use It! Data suggest that Google's OneBox NIH Rx ads effectively reduce organic search visitation driven to pharma sites pushing the traffic to NIH content instead. Is it logical to conclude that Google stands to gain paid ad revenue when pharma marketers have to compete with OneBox ads by buying more paid search placements to make up for the loss of organic search visits?

Welcome to Volume 10, Issue #12 (20 JULY 2011) of Pharma Marketing News.